The inhibitor of NF-κB had significant antitumour effects on oesophagus SCC by promoting apoptosis, and inhibiting proliferation and angiogenesis, as well as reduced the metastasis (Li et al, 2009). The gene discussed is NFKB1; the disease is digestive system neoplasm.